Video

Screening Opportunities and Policy Updates in HCV

Author(s):

Parvez Mantry, MD,Mamta Jain, MD, MPH

Parvez Mantry, MD, examines the question of why so many patients with HCV do not undergo therapy. He also discusses policy updates aimed at improving screening and expanding access to treatment.

Related Videos
Violeta Popov, MD, PhD | Credit: ACG
Satish Rao, MD, PhD | Credit: ACG
Kishore Iyer, MD , MBBS | Credit: Kishore Iyer on LinkedIn
Evan Dellon, MD, MPH | Credit: UNC Chapel Hill
Kishore Iyer, MD, MBBS | Credit: Kishore Iyer on LinkedIn
Bruce Sands, MD | Credit: Alimentiv
Jordan Axelrad, MD, MPH | Credit: ACG
Jacqueline Khalil, DO | Credit: ACG
Braden Kuo, MD | Credit: ACG
Ronnie Fass, MD | Credit: ACG
Related Content
Prior Authorization Managers, Care Management Homes Could Expedite IBD Care
October 30th 2024

Prior Authorization Managers, Care Management Homes Could Expedite IBD Care

Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD
July 18th 2024

Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Abigail Brooks, MA
Brian Lacy, MD, PhD | Credit: Mayo Clinic
October 28th 2024

Brian Lacy, MD, PhD: Profiling Gastric Activity Variations with Multiday Testing

Abigail Brooks, MA
Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030
July 28th 2022

Bindu Anand Balani, MD: Eradicating Hepatitis C Virus by 2030

Kenny Walter
AIMS65 Could Predict Treated Gastrointestinal Bleed Death, Rebleed Risks
October 27th 2024

AIMS65 Could Predict Treated Gastrointestinal Bleed Death, Rebleed Risks

Kevin Kunzmann
Zegocractin Significantly Improves Acute Pancreatitis Symptoms in Phase 2 CARPO
October 27th 2024

Zegocractin Significantly Improves Acute Pancreatitis Symptoms in Phase 2 CARPO

Kevin Kunzmann
© 2024 MJH Life Sciences

All rights reserved.